Back to the Top 100
Nanowear logo

Rank 98MedTech & Devices

Nanowear

Develops cloth-based, nanosensor wearable diagnostics for continuous, clinical-grade remote cardiac and lung monitoring.

Visit website
Signal Score
80.1
Total raised
$30M
Stage
Series B
Founded
2014
Headquarters
New York, USA
Region
North America

Their signal

Utilizing a unique textile-based nanosensor array, Nanowear provides comfortable, continuous remote monitoring, backed by multiple FDA clearances for heart failure and respiratory assessment.

Signal Score 80.1editorial estimate, see how it is built
Capital (25% weight)76

Total raised, quality of investors and recency of the last round.

Growth (25% weight)80

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)85

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)84

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)77

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in MedTech & Devices

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.